miércoles, 24 de enero de 2007

EANM-Courses 2007


Dear all,
it is our pleasure to inform you about the dates of the EANM-Courses 2007.

Clinical PET/CT Courses : Technologists Courses:
Dates: Dates:
27.-28.01.2007 in Italian
17.-18.02.2007 24.-25.03.2007
14.-15.04.2007 09.-10.06.2007
07.-08.07.2007 08.-09.09.2007
10.-11.11.2007 in German 17.-18.11.2007 in German
08.-09.12.2007
Neuroimaging Courses: Therapy - Dosimetry Course:
Dates: Date:
05.-06.05.2007 31.03-01.04.2007
24.-25.11.2007
Cardiovascular Course: Paediatric Course:

Date: Date:
27.-28.10.2007 29.-30.09.2007

How to register
Each course will allow a maximum of 20 participants. Registrations will be accepted on a first come first serve basis, however, EANM members will be given relative priority. Please download and print out the registration form from our homepage
www.eanm.org; Education/ESNM; Educational Facility and fax it back to the EANM-secretariat.
Goals and curriculum
EANM has established the educational facility in order to provide the highest standard of education. A renowned faculty was asked to prepare power point presentations and case studies to cover all courses offered by the EANM.
At each course instructors will cover the presentations in "classroom style" in the lecture room. There will also be ample time for participants to view case studies in 4 viewing rooms, equipped with state of the art multipurpose viewing stations as well as with workstations by all three major manufacturers of PET/CT equipment.
With best regards,
Mirijam Hajek-Ayadi
EANM Educational Facility,
Committee Meetings
European Association of Nuclear Medicine (EANM) Hollandstrasse 14 / Mezzanine 1020 Vienna Austria
Tel: +43-(0)1-212 80 30
Fax: +43-(0)1-212 80 30-9
E-mail: info@eanm.org
URL:
www.eanm.org
EANM´07 Copenhagen: October 13 - 17, 2007

Enviado por: Antonio Maldonado (24/1/07)

Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project

Me sorprende la última frase del abstract.
Es casi rutina para nosotros el monitoreo intra tratamiento, y ha demostrado ser altamente útil en diferenciar los "respondedores" de los "no respondedores".
Lamentablemente no tengo acceso al "early release" del JCO, sería interesante poder contar con el artículo completo.
Enviado por: Victor Jäger (24/1/07)

--------------------
Adjunto referencia de importante publicacion del JCO que marca las pautas sobre PET y PET-CT en linfomas. Lo considero de una gran importancia para la interpretación y manejo de estos estudios


Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma
Journal of Clinical Oncology, 10.1200/JCO.2006.08.2305
JCO Early Release, published online ahead of print Jan 22 2007
Malik E. Juweid,* Sigrid Stroobants, Otto S. Hoekstra, Felix M. Mottaghy, Markus Dietlein, Ali Guermazi, Gregory A. Wiseman, Lale Kostakoglu, Klemens Scheidhauer, Andreas Buck, Ralph Naumann, Karoline Spaepen, Rodney J. Hicks, Wolfgang A. Weber, Sven N. Reske, Markus Schwaiger, Lawrence H. Schwartz, Josee M. Zijlstra, Barry A. Siegel, and Bruce D. Cheson
From the Department of Radiology, University of Iowa, Iowa City, IA; Department of Nuclear Medicine, University Hospital Gasthuisberg, Leuven, Belgium; Departments of Hematology and Nuclear Medicine and PET Research, VU University Medical Center, Amsterdam, the Netherlands; Department of Nuclear Medicine, University of Ulm, Ulm; Department of Nuclear Medicine, University of Cologne, Cologne; Department of Nuclear Medicine, Technische Universitat Munchen, Munich; Department of Medicine, Dresden University of Technology, Dresden, Germany; Department of Oncology Services, Synarc Inc, San Francisco, CA; Department of Radiology, Mayo Clinic, Rochester, MN; Department of Radiology, Mount Sinai School of Medicine; Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY; Centre for Molecular Imaging, University of Melbourne, East Melbourne, Australia; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO; and the Department of Medicine, Georgetown University Hospital, Washington, DC.

Purpose: To develop guidelines for performing and interpreting positron emission tomography (PET) imaging for treatment assessment in patients with lymphoma both in clinical practice and in clinical trials.
Methods: An International Harmonization Project (IHP) was convened to discuss standardization of clinical trial parameters in lymphoma. An imaging subcommittee developed consensus recommendations based on published PET literature and the collective expertise of its members in the use of PET in lymphoma. Only recommendations subsequently endorsed by all IHP subcommittees were adopted.
Recommendations: PET after completion of therapy should be performed at least 3 weeks, and preferably at 6 to 8 weeks, after chemotherapy or chemoimmunotherapy, and 8 to 12 weeks after radiation or chemoradiotherapy. Visual assessment alone is adequate for interpreting PET findings as positive or negative when assessing response after completion of therapy. Mediastinal blood pool activity is recommended as the reference background activity to define PET positivity for a residual mass 2 cm in greatest transverse diameter, regardless of its location. A smaller residual mass or a normal sized lymph node (ie, 1 x 1 cm in diameter) should be considered positive if its activity is above that of the surrounding background. Specific criteria for defining PET positivity in the liver, spleen, lung, and bone marrow are also proposed. Use of attenuation-corrected PET is strongly encouraged. Use of PET for treatment monitoring during a course of therapy should only be done in a clinical trial or as part of a prospective registry.


Enviado por: Antonio Maldonado (24/1/07)

Is PET-CT the only option?

Interesante la reflexión que el Prof. Alavi hace sobre el uso de la PET-CT.
Es una visión que se aproxima bastante a la que tenemos en nuestro pais


Is PET-CT the only option?
Eur J Nucl Med Mol Imaging. 2007 Jan 11 Alavi A., Mavi A., Basu S., Fischman A.
Division of Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 19104, USA, alavi@oasis.rad.upenn.edu.


Enviado por: Antonio Maldonado (23/1/07)

Nueva actualización de la situación de la PET y PET-CT en Europa.

Nueva actualización de la situación de la PET y PET-CT en Europa.

Study: PET posts double-digit gains in Western Europe
http://www.auntminnie.com/index.asp?sec=sup&sub=mol&pag=dis&ItemId=74330

Enviado por: Antonio Maldonado (23/1/07)

miércoles, 10 de enero de 2007

URL largas

Como posible solucion cuando se envia un url muy larga a la lista y queda cortada, podéis utilizar, por ejemplo, Tinyurl:

http://tinyurl.com/

Introduces la url larga, aceptas y copias la nueva url que aparece.

Enviado por: Antonio Maldonado (10/1/07)

martes, 9 de enero de 2007

PET/CT in Cancer Patient Management - JNM January 2007

PET/CT in Cancer Patient Management - Johannes Czernin, Guest Editor: 1
January 2007; Vol. 48, Supplement to Issue 1
---------------------------------------------------------------
PET/CT in Cancer Patient Management
-----------------------------------------------------------------
Commentary
Lalitha K. Shankar and Daniel C. Sullivan
J Nucl Med 2007;48 1S

Introduction
Johannes Czernin and Heinrich R. Schelbert
J Nucl Med 2007;48 2S-3S

Screening for Cancer with PET and PET/CT: Potential and Limitations
Heiko Schoder and Mithat Gonen
J Nucl Med 2007;48 4S-18S

Integrating PET and PET/CT into the Risk-Adapted Therapy of Lymphoma
Yvette L. Kasamon, Richard J. Jones, and Richard L. Wahl
J Nucl Med 2007;48 19S-27S

Early Detection of Cancer Recurrence: 18F-FDG PET/CT Can Make a Difference
in Diagnosis and Patient Care

Ora Israel and Abraham Kuten
J Nucl Med 2007;48 28S-35S

Monitoring Cancer Treatment with PET/CT: Does It Make a Difference?
Wolfgang A. Weber and Robert Figlin
J Nucl Med 2007;48 36S-44S

Can PET/CT Replace Separate Diagnostic CT for Cancer Imaging? Optimizing CT
Protocols for Imaging Cancers of the Chest and Abdomen

Hilmar Kuehl, Patrick Veit, Sandra J. Rosenbaum, Andreas Bockisch, and
Gerald Antoch
J Nucl Med 2007;48 45S-57S

Clinical Role of 18F-FDG PET/CT in the Management of Squamous Cell
Carcinoma of the Head and Neck and Thyroid Carcinoma
Andrew Quon, Nancy J. Fischbein, I. Ross McDougall, Quynh-Thu Le,
Billy W. Loo, Jr., Harlan Pinto, and Michael J. Kaplan
J Nucl Med 2007;48 58S-67S

PET-Based Treatment Planning in Radiotherapy: A New Standard?
Vincent Gregoire, Karin Haustermans, Xavier Geets, Sarah Roels, and
Max Lonneux
J Nucl Med 2007;48 68S-77S

Improvements in Cancer Staging with PET/CT: Literature-Based Evidence as of
September 2006

Johannes Czernin, Martin Allen-Auerbach, and Heinrich R. Schelbert
J Nucl Med 2007;48 78S-88S

Enviado por: Antonio Maldonado (9/1/07)




lunes, 1 de enero de 2007

Nuevo Blog sobre Noticias PET y PET-CT

Desde hace varias semanas está disponible un nuevo blog con todas las noticias sobre el mundo PET y PET-CT. Los interesados en acceder al mismo, pueden hacerlo enviando un e-mail a: antonio_maldonado@telefonica.net

Enviado por: Antonio Maldonado (2/1/07)

La Unidad PET del Marqués de Valdecilla multiplica su actividad y mejora la asistencia y la investigación

La Unidad PET del Marqués de Valdecilla multiplica su actividad y mejora la asistencia y la investigación

http://www.diariomedico.com/edicion/diario_medico/gestion/es/desarrollo/723583.html

Enviado por: Antonio Maldonado (2/1/07)